IN2014CN04861A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN04861A IN2014CN04861A IN4861CHN2014A IN2014CN04861A IN 2014CN04861 A IN2014CN04861 A IN 2014CN04861A IN 4861CHN2014 A IN4861CHN2014 A IN 4861CHN2014A IN 2014CN04861 A IN2014CN04861 A IN 2014CN04861A
- Authority
- IN
- India
- Prior art keywords
- factor
- sulphonylaminopyrrolidinone
- drugs
- compounds
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11306733.4A EP2606893A1 (fr) | 2011-12-21 | 2011-12-21 | Dérivés de la sulphonylaminopyrrolidinone, leur préparation et leur application thérapeutique |
PCT/EP2012/076224 WO2013092756A1 (fr) | 2011-12-21 | 2012-12-19 | Dérivés sulfonylaminopyrrolidinone, préparation et application thérapeutique de ceux-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CN04861A true IN2014CN04861A (fr) | 2015-09-18 |
Family
ID=47428640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN4861CHN2014 IN2014CN04861A (fr) | 2011-12-21 | 2012-12-19 |
Country Status (18)
Country | Link |
---|---|
US (1) | US9150544B2 (fr) |
EP (2) | EP2606893A1 (fr) |
JP (1) | JP6104936B2 (fr) |
KR (1) | KR20140106703A (fr) |
CN (1) | CN104136030B (fr) |
AR (1) | AR089397A1 (fr) |
AU (1) | AU2012357123B2 (fr) |
BR (1) | BR112014014869A2 (fr) |
CA (1) | CA2859575A1 (fr) |
ES (1) | ES2559854T3 (fr) |
IL (1) | IL233238A (fr) |
IN (1) | IN2014CN04861A (fr) |
MX (1) | MX347620B (fr) |
RU (1) | RU2014129787A (fr) |
SG (1) | SG11201403336QA (fr) |
TW (1) | TWI568727B (fr) |
UY (1) | UY34543A (fr) |
WO (1) | WO2013092756A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
CN104557928B (zh) * | 2015-02-14 | 2016-08-24 | 佛山市赛维斯医药科技有限公司 | 一种含二环酰胺结构凝血因子Xa抑制剂、其制备方法及其用途 |
AR117006A1 (es) * | 2018-11-08 | 2021-07-07 | Glaxosmithkline Ip Dev Ltd | Compuesto de 1,3-azol sustituido, composición farmacéutica que lo comprende y su uso para la fabricación de un medicamento |
EP4070658A1 (fr) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Utilisation de composés anticoagulants comme rodenticides |
CN113264819A (zh) * | 2021-05-25 | 2021-08-17 | 都创(上海)医药开发有限公司 | 一种基于连续流反应技术快速合成3-溴-2-氟苯甲醛的方法 |
TW202404583A (zh) | 2022-06-08 | 2024-02-01 | 加拿大商再諾製藥公司 | 吡啶胺衍生物及其作為鉀通道調節劑之用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4121947A1 (de) * | 1991-07-03 | 1993-01-07 | Basf Ag | 2-(3-(4-amidino-phenyl))-propionsaeurederivate, ihre herstellung und verwendung |
US6281227B1 (en) * | 1996-12-13 | 2001-08-28 | Aventis Pharma Deutschland Gmbh | Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
PL333921A1 (en) * | 1996-12-13 | 2000-01-31 | Rhone Poulenc Rorer Pharma | N-(heteroalkyl)-azaheterocyclyamides of sulphonic acids or other n-(heteroalkyl)-azaheterocyclylamide compounds |
US6602864B1 (en) | 1996-12-13 | 2003-08-05 | Aventis Pharma Deutschland Gmbh | Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds |
IL123986A (en) * | 1997-04-24 | 2011-10-31 | Organon Nv | Medicinal compounds |
-
2011
- 2011-12-21 EP EP11306733.4A patent/EP2606893A1/fr not_active Withdrawn
-
2012
- 2012-12-19 US US14/366,402 patent/US9150544B2/en not_active Expired - Fee Related
- 2012-12-19 MX MX2014007671A patent/MX347620B/es active IP Right Grant
- 2012-12-19 CA CA2859575A patent/CA2859575A1/fr not_active Abandoned
- 2012-12-19 WO PCT/EP2012/076224 patent/WO2013092756A1/fr active Application Filing
- 2012-12-19 BR BR112014014869A patent/BR112014014869A2/pt not_active Application Discontinuation
- 2012-12-19 ES ES12805694.2T patent/ES2559854T3/es active Active
- 2012-12-19 JP JP2014547988A patent/JP6104936B2/ja not_active Expired - Fee Related
- 2012-12-19 CN CN201280070270.9A patent/CN104136030B/zh not_active Expired - Fee Related
- 2012-12-19 AU AU2012357123A patent/AU2012357123B2/en not_active Ceased
- 2012-12-19 EP EP12805694.2A patent/EP2793887B1/fr not_active Not-in-force
- 2012-12-19 IN IN4861CHN2014 patent/IN2014CN04861A/en unknown
- 2012-12-19 SG SG11201403336QA patent/SG11201403336QA/en unknown
- 2012-12-19 RU RU2014129787A patent/RU2014129787A/ru not_active Application Discontinuation
- 2012-12-19 KR KR1020147019821A patent/KR20140106703A/ko not_active Application Discontinuation
- 2012-12-20 TW TW101148829A patent/TWI568727B/zh not_active IP Right Cessation
- 2012-12-21 AR ARP120104901A patent/AR089397A1/es unknown
- 2012-12-21 UY UY0001034543A patent/UY34543A/es not_active Application Discontinuation
-
2014
- 2014-06-18 IL IL233238A patent/IL233238A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI568727B (zh) | 2017-02-01 |
IL233238A (en) | 2016-10-31 |
EP2606893A1 (fr) | 2013-06-26 |
AU2012357123B2 (en) | 2016-12-15 |
UY34543A (es) | 2013-06-28 |
CA2859575A1 (fr) | 2013-06-27 |
ES2559854T3 (es) | 2016-02-16 |
WO2013092756A1 (fr) | 2013-06-27 |
CN104136030B (zh) | 2017-03-01 |
US9150544B2 (en) | 2015-10-06 |
IL233238A0 (en) | 2014-08-31 |
JP2015502382A (ja) | 2015-01-22 |
RU2014129787A (ru) | 2016-02-10 |
MX347620B (es) | 2017-05-04 |
CN104136030A (zh) | 2014-11-05 |
MX2014007671A (es) | 2014-11-25 |
BR112014014869A2 (pt) | 2017-06-13 |
EP2793887B1 (fr) | 2015-10-21 |
SG11201403336QA (en) | 2014-07-30 |
AU2012357123A1 (en) | 2014-07-10 |
US20140329801A1 (en) | 2014-11-06 |
TW201331195A (zh) | 2013-08-01 |
EP2793887A1 (fr) | 2014-10-29 |
AR089397A1 (es) | 2014-08-20 |
JP6104936B2 (ja) | 2017-03-29 |
KR20140106703A (ko) | 2014-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2768937T3 (pl) | Preparaty, ich zastosowanie jako środków do mycia naczyń lub do wytwarzania środków do mycia naczyń i ich wytwarzanie | |
PH12014501702A1 (en) | Imidazopyrrolidinone compounds | |
IL231536A (en) | Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases | |
NZ709392A (en) | Synergistic bacterial compositions and methods of production and use thereof | |
GB201118656D0 (en) | New compounds | |
MX349004B (es) | Nuevos compuestos. | |
MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
CO6791606A2 (es) | Composiciones y métodos para el tratamiento en aplicaciones clínicas de amplio espectro, no diferenciadas o combinadas | |
IN2014CN04861A (fr) | ||
MY176987A (en) | 2-substituted cephem compounds | |
MX356728B (es) | Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2. | |
PL2768936T3 (pl) | Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie | |
AP2014007399A0 (en) | Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament | |
EP2727614A4 (fr) | Système de purification du sang | |
BR112013022052A2 (pt) | ligantes antagonísticos de dr3 | |
IN2015DN03998A (fr) | ||
PL2841549T3 (pl) | Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie | |
MX357284B (es) | Compuestos de quinona para tratar enfermedades mediadas por ape1. | |
IN2014DN10449A (fr) | ||
EP2825194A4 (fr) | Utilisation d'antithrombine dans le traitement de la pré-éclampsie | |
IL236776A0 (en) | Use of antithrombin in extracorporeal membrane oxidation | |
PH12014501176A1 (en) | Anticoagulant reversal agents | |
DK2175877T3 (da) | Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme | |
UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
AU2012307449A8 (en) | Sulfonic acid salts of heterocyclylamide-substituted imidazoles |